Abstract:IL-17, the hallmark cytokine of Th17 cells, plays a pivotal role in the pathogenesis of autoimmune diseases, including encephalomyelitis. In the central nervous system, neuroglial cells are the main residents that express IL-17R and respond to IL-17 by producing chemokines/cytokines and boosting local inflammation. Factors that influence the IL-17R expression in neuroglial cells can also exert their impacts on the outbreak, progression and outcome of encephalomyelitis. Here, we reported that Toll-like receptor signaling has its bias for promoting the IL-17RA, but not the IL-17RC, expression in mouse neuroglial cells in a T cell infiltration independent manner. Elevated IL-17R functionally responded to IL-17 by secreting more chemokines and accelerating CD4 cell migration. First, real-time PCR confirmed that the expression of Il-17ra, but not Il-17rc, was significantly increased in the brain and spinal cord of EAE-induced mice. This effect was elicited by something in complete Freund's adjuvant (CFA), because markedly increased IL-17R was detected in mice immunized with CFA only, even though no evidence of EAE was found. Furthermore, in Rag1(-/-) mice, it was confirmed that CFA could augment the IL-17RA expression in the CNS in the absence of T cell infiltration. In vivo immunization with TLR ligands and in vitro treatment of purified neuroglial cells demonstrated that TLR ligands directly and effectively evoke the IL-17RA expression in the CNS and in cultured astrocytes, microglia and oligodendrocytes. LPS was the most effective inducer of the IL-17RA expression in astrocytes, and polyIC was superior to LPS for microglia and oligodendrocytes. Activated CD4 cells can also promote the secretion of chemokines by LPS pre-treated astrocytes, and hence accelerate the migration of CD4 cells, which was blocked by the neutralization of IL-17RA on the surface of the astrocyte. Taken together, we concluded that TLR signaling can directly stimulate the expression of IL-17RA, but not IL-17RC, in neuroglial cells, which functionally respond to IL-17A by secreting chemokines, accelerating CD4 cell migration, and contributing to the pathogenesis of encephalomyelitis.

Cytotoxic Effect of IL-17A on Neural Stem Cells As a Mechanism Underlying Th17-cell-induced Proinflammatory Demyelination (59.7)

Inhibitory effect of IL-17 on neural stem cell proliferation and neural cell differentiation

Th17 cell promotes apoptosis of IL-23R+ neurons in experimental autoimmune encephalomyelitis

IL-17A Promotes Granulocyte Infiltration, Myelin Loss, Microglia Activation, and Behavioral Deficits During Cuprizone-Induced Demyelination

IL-17A expression by both T cells and non-T cells contribute to HSV-IL-2-induced CNS demyelination

Act1 Mediates IL-17–induced EAE Pathogenesis Selectively in NG2+ Glial Cells

Interleukin-17A: the Key Cytokine in Neurodegenerative Diseases

Pro-inflammatory T helper 17 directly harms oligodendrocytes in neuroinflammation

Neutralizing IL-17 protects the optic nerve from autoimmune pathology and prevents retinal nerve fiber layer atrophy during experimental autoimmune encephalomyelitis

IL-17 controls central nervous system autoimmunity through the intestinal microbiome

Toll-like Receptor Signaling Directly Increases Functional IL-17RA Expression in Neuroglial Cells.

The novel small-molecule TPN10456 inhibits Th17 cell differentiation and protects against experimental autoimmune encephalomyelitis.

CNS-targeted production of IL-17A induces glial activation, microvascular pathology and enhances the neuroinflammatory response to systemic endotoxemia

IL-17A Mediates Demyelination by Activating A1 Astrocytes via SOCS3 During Angiostrongylus cantonensis Infection

Il-17 Induced Notch1 Activation In Oligodendrocyte Progenitor Cells Enhances Proliferation And Inflammatory Gene Expression

Il-9 Signaling Affects Central Nervous System Resident Cells During Inflammatory Stimuli

IL‐17 and Glutamate Excitotoxicity in the Pathogenesis of Multiple Sclerosis

Myelin oligodendrocyte glycoprotein reactive Th17 cells drive Janus Kinase 1 dependent transcriptional reprogramming in astrocytes and alter cell surface cytokine receptor profiles during experimental autoimmune encephalomyelitis

Interleukin-17 (Il-17)-induced Microrna 873 (Mir-873) Contributes to the Pathogenesis of Experimental Autoimmune Encephalomyelitis by Targeting A20 Ubiquitin-Editing Enzyme

Enhanced IL-9 Receptor (IL-9R) Expression in CNS Resident Cells in the Pathogenesis of EAE (101.31)

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation